Current Neuro-Oncology

Volume 28 Number 25
30 September 2026

Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 25, 30 September

Ruggiero A, Attinà G, Placidi G, D'Agostino E, Amato A, Verdolotti T, Mastrangelo S, Falsini B.
Long-term outcomes after a randomized phase II trial of nerve growth factor eye drops for optic pathway gliomas: four-year follow-up findings in children.
J Neurooncol. 2026 Sep 1;179(2):67. doi: 10.1007/s11060-026-05777-z. PMID: 42681266. Trial registration ID: NCT05733572. ˍ

Jackson JS, Schaffer DH, Harris LJ.
Nitrosoureas Toxicity.
StatPearls Publishing. 2026 Sep 8. Bookshelf ID: NBK599513 PMID: 38261709. ˍ

Liu J, Wu P, Li D, Gu X, Zhao B, Ma R, Tan B, Shang D, Wu Y, Zhou J, Lin C, Sun N, Zhang C, He J.
Efficacy of immune checkpoint inhibitors in female patients with cancer: a systematic review and meta-analysis.
Sci China Life Sci. 2026 Sep 15. doi: 10.1007/s11427-025-3225-1. PMID: 42752777˰ ˍ

Chen L, Gao Y, Zhong J, Zhang N.
Beyond the tumour microenvironment: Harnessing border immunity for glioblastoma immunotherapy.
Clin Transl Med. 2026 Sep 18;16(9):e70841. doi: 10.1002/ctm2.70841. PMID: 42755438. ˍ

Ghoche MT, Miki K, Yuan F, Mantica M, Agnihotri S, McBrayer SK, Abdullah KG.
Metabolic modulation of glioblastoma by dietary intervention: a systematic review.
J Neurooncol. 2026 Sep 18;179(3):90. doi: 10.1007/s11060-026-05779-x. PMID: 42758370˰ ˍ

The role of non-malignant cell types in the tumor microenvironment in accelerating DNA repair in neoplastic cells

Sravya P, Altay LN, Do K, Freeman J, Gokul A, Liang N, Scott AJ, Xu J, Korimerla N, Lin A, Wang H, Wilder-Romans K, Singer A, O'Brien A, Animasahun O, Meghdadi B, Baker E, Peterson ER, McCulla EC, Zhu Z, Thomas D, Andren A, Wong H, Sajjakulnukit P, Zhang L, Shankar S, Ravikumar V, Lee ZH, Carrion JAN, Bhadury S, Miller CR, Sarkaria JN, Heth JA, Huse JT, Camelo-Piragua S, Morgan MA, Lawrence TS, Rao A, Lyssiotis C, Al-Holou W, Nagrath D, Zhou W, Wahl DR.
Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance.
Res Sq [Preprint]. 2026 Sep 18:rs.3.rs-10976328. doi: 10.21203/rs.3.rs-10976328/v1. PMID: 42780293. ˍ

Wang L, Ding J, Liu X, Li T, Liu Y, You Y, Yu Y, Zheng Y.
Safety and efficacy of sonodynamic therapy combined with Stupp regimen in controlling postoperative residual lesions of glioblastoma: A prospective pilot phase I study.
Photodiagnosis Photodyn Ther. 2026 Sep 18;61:105655. doi: 10.1016/j.pdpdt.2026.105655. PMID: 42759826. Trial Ethics Approval No 2024-KY-0621–002. ˍ

Nicolaides T, Hoogendijk R, Jaeger-Krause M, Dhall G, Goldman S, Gajjar A, Kilburn L, Leary S, Minturn J, Whipple N, Ramakrishnan D, Long-Boyle J, Aboian M, Prados M, Molinaro AM, Mueller S.
Efficacy Study of Vemurafenib in Children With Recurrent or Progressive BRAF^V600E- or BRAF^InsT-Mutant Brain Tumors: PNOC002.
JCO Precis Oncol. 2026 Sep 23;10(9):e2600558. doi: 10.1200/PO-26-00558. PMID: 42777179. Trial registration ID: PNOC002. ˍ

Zadeh SMM, Kalantari S, Dastgerdi SS, Sharifi H, Mohammadi M, Roudi R, Shariftabrizi A, Kalantari A, Ahmadvand D, Yazdi M, Nedaeinia R.
Efficacy of CAR-T-Cell-Based Immunotherapies in Patients With Glioma: A Systematic Review and Meta-Analysis.
J Cell Mol Med. 2026 Sep 25;30(18):e71358. doi: 10.1111/jcmm.71358. PMID: 42791198. ˍ

Costa Filho VO, Rabenhorst SHB, Mesquita FP.
Next-generation CAR-T therapy for malignant brain tumors: latest updates from the 2026 AACR Annual Meeting.
Exp Hematol Oncol. 2026 Sep 28;15(1):101. doi: 10.1186/s40164-026-00834-9. PMID: 42806401. ˍ

Jain PV, Rumler S, North P.
Infant-Type Hemispheric Glioma With NTRK Fusion Responds to Larotrectinib.
Cureus. 2026 Aug 6;18(8):e114069. doi: 10.7759/cureus.114069. PMID: 42701716. ˍ

Aman RA, Wayne TMLS, Hamdilah F, Adriantama MW.
Impact of PD-1 inhibitor immunotherapy on survival in patients with newly diagnosed and recurrent glioblastoma: a systematic review of comparative evidence.
Folia Med (Plovdiv). 2026 Aug 13;68(4). doi: 10.3897/folmed.68.e184377. PMID: 42677757. ˍ

Gallus M, Yamamichi A, Arrieta VA, Nejo T, Phung L, Saijo A, Chuntova P, Lu J, Phyu S, Benway HL, Zhao A, Okada K, Watchmaker PB, Haegelin J, Lakshmanachetty S, Habashy K, Young JS, Canney M, Stupp R, Salazar AM, Sonabend AM, Okada H.
Ultrasound-mediated blood-brain barrier modulation enhances T-cell access but requires immune activation for effective CNS immunity.
bioRxiv [Preprint]. 2026 Aug 17:2026.08.14.744698. doi: 10.64898/2026.08.14.744698. PMID: 42718384. ˍ

Zhang H, Sun L, Yun Z, Yin X, Li Y, Wu J, Dong G.
Comparative efficacy of therapeutic strategies for recurrent or refractory glioblastoma: a systematic review and network meta-analysis.
Front Neurol. 2026 Aug 20;17:1896062. doi: 10.3389/fneur.2026.1896062. PMID: 42694176. ˍ

Ouazzani Chahdi H, Akammar A, Chaouche I, El Bouardi N, Haloua M, Alami B, Alaoui Lamrani MY, Maaroufi M, Boubbou M.
Late peritoneal metastases of medulloblastoma following ventriculoperitoneal shunting: A case report.
Radiol Case Rep. 2026 Aug 26;21(11):5593-5597. doi: 10.1016/j.radcr.2026.07.115. PMID: 42699746. ˍ